Erlotinib Tarbis 150 mg film-coated tablets Malta - Englisch - Medicines Authority

erlotinib tarbis 150 mg film-coated tablets

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - erlotinib hydrochloride - film-coated tablet - erlotinib hydrochloride 150 mg - antineoplastic agents

ERLOTINIB TARO 100 MG Israel - Englisch - Ministry of Health

erlotinib taro 100 mg

taro international ltd, israel - erlotinib as hydrochloride - film coated tablets - erlotinib as hydrochloride 100 mg - erlotinib - non-small cell lung cancer (nsclc): erlotinib taro is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations. erlotinib taro is indicated for switch maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations and stable disease after first-line chemotherapy. erlotinib taro is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.pancreatic cancer: erlotinib taro is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

ERLOTINIB TARO 150 MG Israel - Englisch - Ministry of Health

erlotinib taro 150 mg

taro international ltd, israel - erlotinib as hydrochloride - film coated tablets - erlotinib as hydrochloride 150 mg - erlotinib - non-small cell lung cancer (nsclc): erlotinib taro is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations. erlotinib taro is indicated for switch maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations and stable disease after first-line chemotherapy. erlotinib taro is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.pancreatic cancer: erlotinib taro is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

ERLOTINIB TARO 25 MG Israel - Englisch - Ministry of Health

erlotinib taro 25 mg

taro international ltd, israel - erlotinib as hydrochloride - film coated tablets - erlotinib as hydrochloride 25 mg - erlotinib - non-small cell lung cancer (nsclc): erlotinib taro is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations. erlotinib taro is indicated for switch maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations and stable disease after first-line chemotherapy. erlotinib taro is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.pancreatic cancer: erlotinib taro is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

Tarceva 100 mg Jordanien - Englisch - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

tarceva 100 mg

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - erlotinib 100 mg - 100 mg

Tarceva F.C.Tablet 150 mg Jordanien - Englisch - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

tarceva f.c.tablet 150 mg

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - erlotinib 150 mg - 150 mg

Varlota 100 mg film-coated tablets Malta - Englisch - Medicines Authority

varlota 100 mg film-coated tablets

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - erlotinib hydrochloride - film-coated tablet - erlotinib hydrochloride 100 mg - antineoplastic agents